Načítá se...
β-nicotinamide mononucleotide (NMN) production in Escherichia coli
Diabetes is a chronic and progressive disease with continuously increasing prevalence, rising financial pressure on the worldwide healthcare systems. Recently, the insulin resistance, hallmark of type 2 diabetes, was cured in mice treated with NAD(+) precursor β-nicotinamide mononucleotide (NMN), no...
Uloženo v:
| Vydáno v: | Sci Rep |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Nature Publishing Group UK
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6095924/ https://ncbi.nlm.nih.gov/pubmed/30115969 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-018-30792-0 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|